OcuMension
IPOPublic · Shanghai, China · Founded 2018
- Headquarters
- Shanghai
- Employees
- 201–500
- Founded
- 2018
- Business Model
- B2B
- Website
- ocumension.com
- Last Round
- Series BJul 2019
- Type
- Public
About
Ocumension is a clinical-stage biotechnology company focused on developing and commercializing ophthalmology therapeutics in China.
Summary
OcuMension is a Life Sciences company based in Shanghai, China, founded in 2018. Its most recent funding was a Series B round in Jul 2019.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...